https://www.marketscreener.com/quote/stock/IO-BIOTECH-INC-129052295/news/IO-Biotech-Completes-Enrollment-of-380-Patients-in-Pivotal-Phase-3-Trial-in-Advanced-Melanoma-45304963/?utm_source=telegram&utm_medium=social&utm_campaign=share